Aerie Pharmaceuticals Inc
AERIDelisted Nov 21, 2022- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001337553
Aerie Pharmaceuticals Inc was delisted on Nov 21, 2022; its insiders filed their last Form 4 on Nov 21, 2022; 156 institutions reported holding it in 13F filings for Q3 2022, worth $710.6M in total; no superinvestor held it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Aerie Pharmaceuticals Inc insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Aerie Pharmaceuticals Inc, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Gryska David W | Director | 0Indirect | Nov 21, 2022 | 0 |
| McGraw Benjamin F III | Director | 0 | Nov 21, 2022 | 0 |
| McHugh Julie | Director | 0 | Nov 21, 2022 | 0 |
| McDonnell Peter J | Director | 0 | Nov 21, 2022 | 0 |
| Kopczynski Casey C. | Chief Scientific Officer | 0 | Nov 21, 2022 | 0 |
| du Toit Michael | Director | 0 | Nov 21, 2022 | 0 |
| Croarkin Richard | Director | 0 | Nov 21, 2022 | 0 |
| LaRocca John | General Counsel | 0 | Nov 21, 2022 | 0 |
| Kannan Raj | Chief Executive Officer | 0 | Nov 21, 2022 | 0 |
| Calabrese Jeffrey | Vice President of Finance | 0 | Nov 21, 2022 | 0 |
| Lang Peter Frederick | Chief Financial Officer | 0 | Nov 21, 2022 | 0 |
| Mitro Thomas A | President and COO | 81,418 | Feb 9, 2022 | 0 |
| Hollander David | Chief R&D Officer | 30,749 | Feb 8, 2022 | 0 |
| McGinley Kathleen | CHRO & VP, Corp Services | 23,993 | Feb 1, 2022 | 0 |
| Staten Christopher | Interim CFO | 21,710 | Aug 17, 2021 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
No insider trades match these filters.